June 4th - $CNS Pharmaceuticals (CNSP.US)$ is about to implement a 1-for-50 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from June 5th, 2024.
$CNS Pharmaceuticals (CNSP.US)$ slipped 39.87% and closed at $0.13 on June 3rd with a turnover of $1.35 million. $CNS Pharmaceuticals (CNSP.US)$ now has a total market capitalization of $1.54 million.
What Is a Reverse Stock Split?
A reverse stock split consolidates the number of existing shares of stock held by shareholders into fewer shares. It does not directly impact a company's value. And it can signal a company in distress since it raises the value of otherwise low-priced shares.
Note:
The company's actual implementation is subject to the final disclosure submitted to the exchange. The information provided herein is for reference only.